Center for Pancreatic Cancer Research

People

  1. Soares
    Soares
  2. Lowe
    Lowe
  3. Rahimi-Keshari
    Rahimi-Keshari
  4. Massague
    Massague
  5. Drebin
    Drebin
  6. Reidy
    Reidy
  7. Wong
    Wong
  8. Basturk
    Basturk
  9. Reyngold
    Reyngold
  10. Tammela
    Tammela
  11. Balachandran
    Balachandran
  12. Resh
    Resh
  13. D'Angelica
    D'Angelica
  14. Diaz
    Diaz
  15. Solomon
    Solomon

Description

Publications

  1. Journal of Clinical Oncology (833)
  2. Annals of Surgical Oncology (308)
  3. Cancer Research (221)
  4. International Journal of Radiation Oncology, Biology, Physics (187)
  5. Modern Pathology (187)
  6. Laboratory Investigation (180)
  7. Clinical Cancer Research (146)
  8. Cancer (126)
  9. Journal of Nuclear Medicine (123)
  10. Journal of the American College of Surgeons (112)

Publishers

  1. American Society of Clinical Oncology (870)
  2. Elsevier Inc. (726)
  3. Springer (716)
  4. Nature Publishing Group (541)
  5. Elsevier Science, Inc. (456)
  6. American Association for Cancer Research (364)
  7. Wiley Blackwell (347)
  8. Lippincott Williams & Wilkins (337)
  9. Oxford University Press (226)
  10. Nature Research (200)

Types of Work

Recent Works

  1. Diseases of the gallbladder
    Book Section

    Basturk, O.; Adsay, N. V.
    In Burt, A. D.; Ferrell, L. D.; Hübscher, S. G. (Eds.) MacSween's Pathology of the Liver. 8th ed (2024)

    Fulltext@MSK | Save
  2. A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer
    Meeting Abstract

    Abdelhamid Ahmed, A. H.; Russell, M. D.; Kyriazidis, N.; Silver Karcioglu, A.; Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Wong, R. J.; Busaidy, N. L.; Zafereo, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  3. A phase 1b, open-label, two-part safety, tolerability, and efficacy study of a soluble beta-glucan (odetiglucan) in combination with a CD40 agonistic monoclonal antibody (CDX-1140) in patients with metastatic pancreatic adenocarcinoma whose disease did not progress during first-line (1L) chemotherapy
    Meeting Abstract

    O'Hara, M. H.; Wattenberg, M. M.; Garrido-Laguna, I.; O'Reilly, E. M.; Yellin, M. J.; Keler, T.; Gargano, M. A.; Niles, N.; Drees, J.; Bose, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save